Literature DB >> 17572369

Patients' descriptions of visual sensations during pars plana vitrectomy under retrobulbar anesthesia.

Eiko Sugisaka1, Kei Shinoda, Susumu Ishida, Yutaka Imamura, Yoko Ozawa, Hajime Shinoda, Kotaro Suzuki, Kazuo Tsubota, Makoto Inoue.   

Abstract

PURPOSE: To investigate the visual sensations experienced by patients during vitrectomy under retrobulbar anesthesia.
DESIGN: Cross-sectional study.
METHODS: Fifty-six men and 45 women with a mean age of 62.2 +/- 11.9 years (range, 30 to 89 years) were studied. Twenty-two eyes had an idiopathic epiretinal membrane, 10 had an idiopathic macular hole, 29 had macular edema (16 resulting from diabetic retinopathy and 13 resulting from retinal vein occlusion), 14 had proliferative diabetic retinopathy, 13 had rhegmatogenous retinal detachment, four had proliferative vitreoretinopathy, and nine had other retinal diseases. The patients were questioned about their visual sensations during and within three hours after vitrectomy, which was performed under retrobulbar anesthesia using 2% lidocaine hydrochloride. Visual sensations perceived by the patients during surgery were reviewed.
RESULTS: Ninety-one of the 101 patients experienced some type of visual sensation during the vitrectomy. Ninety-one (90.1%) patients reported seeing lights, 73 (72.3%) patients reported seeing one or more colors, and 57 (56.4%) patients reported seeing movements or moving objects. Of these latter 57 patients, 54 saw instruments and nine (8.9%) saw the surgeon's fingers or hands. In the 94 cases that had triamcinolone-assisted vitrectomy, 35 (37.2%) reported seeing many diffuse whirling black spots. Six patients (5.9%) found the visual experiences frightening.
CONCLUSIONS: Visual sensations are experienced by approximately 90% of the patients despite full pain control, and surgeons should warn patients of these possibilities because they can be frightening. This should minimize patients' anxiety and stress during the surgery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17572369     DOI: 10.1016/j.ajo.2007.05.001

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Visual perceptions induced by intravitreal injections.

Authors:  W K Ngo; C S H Tan
Journal:  Eye (Lond)       Date:  2012-02-17       Impact factor: 3.775

2.  Images created in a model eye during simulated cataract surgery can be the basis for images perceived by patients during cataract surgery.

Authors:  M Inoue; A Uchida; K Shinoda; Y Taira; T Noda; K Ohnuma; H Bissen-Miyajima; A Hirakata
Journal:  Eye (Lond)       Date:  2014-05-02       Impact factor: 3.775

3.  Patients' subjective visual experiences during vitreous surgery under local anesthesia.

Authors:  Ji-Feng Yu; Li Liang; Yu-Qin Wen; Li Liu; Yi-Fei Huang
Journal:  Int J Clin Exp Med       Date:  2011-09-15

4.  Editorial.

Authors:  Alexander Bialasiewicz
Journal:  Middle East Afr J Ophthalmol       Date:  2008-01

Review 5.  Local versus general anaesthesia for adults undergoing pars plana vitrectomy surgery.

Authors:  Ana Licina; Sharan Sidhu; Jing Xie; Crispin Wan
Journal:  Cochrane Database Syst Rev       Date:  2016-09-19

6.  Surgical outcomes of macular hole and epimacular membrane treatment in patients with intraoperative amaurosis under sub-Tenon's anesthesia.

Authors:  Qi Zhang; Zijing Huang; Dingguo Huang; Haoyu Chen; Dezhi Zheng; Jianlong Zheng; Peimin Lin; Weiqi Chen
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

7.  Incidence and impact factors of intraoperative loss of light perception under sub-Tenon's anesthesia in patients with macular diseases.

Authors:  Dezhi Zheng; Zijing Huang; Guihua Zhang; Dingguo Huang; Guoqiao Lin; Weiqi Chen
Journal:  Eye (Lond)       Date:  2019-06-20       Impact factor: 3.775

8.  Assessment of Macular Function during Vitrectomy: New Approach Using Intraoperative Focal Macular Electroretinograms.

Authors:  Celso Soiti Matsumoto; Kei Shinoda; Gaku Terauchi; Harue Matsumoto; Atsushi Mizota; Yozo Miyake
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.